The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking
here.
According to Fortune Business Insights, the global non-steroidal anti-inflammatory drugs (NSAIDs) market was valued at USD 15.58 billion in 2019 and is projected to reach USD 32.33 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period. North America dominated the market in 2019, holding a share of 44.03%.
Published by
sachi toshniwal,
2025-06-05 01:11:47
Strategic Overview of the Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Industry
According to Fortune Business Insights, the global non-steroidal anti-inflammatory drugs (NSAIDs) market was valued at USD 15.58 billion in 2019 and is projected to reach USD 32.33 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period. North America dominated the market in 2019, holding a share of 44.03%.
Keywords: non-steroidal anti-inflammatory drugs (NSAIDs) market
Click to View FlipBook Version